// you’re reading...

General Biotechnology

Pharma Financial Squeeze Bodes Ill for Genomics

By Yali ⋅ June 17, 2002 ⋅ Email This Post Email This Post ⋅ Print This Post Print This Post ⋅ Post a comment

Pharma Financial Squeeze Bodes Ill for Genomics
‘Caution: Tougher Times Ahead’ may be an apt sign for biotech in general and genomics in particular, according to a panel of leading venture capitalists.

Print This Post

Discussion

No comments for “Pharma Financial Squeeze Bodes Ill for Genomics”

Post a comment

Building Biotechnology - Starting, Managing, and Understanding Biotechnology Companies   The Business of Biotechnology - Profit From the Growing Influence of Biotechnology
Best Practices in Biotechnology Business Development Best Practices in Biotechnology Education
Journal of Commercial Biotechnology 
DrugPatentWatch.com